PVLA

Palvella Therapeutics, Inc.NASDAQHealthcare

$123.46+2.56%ClosedMarket Cap: $1.46B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-31	Chardan Capital	—	Buy	—
2026-03-24	HC Wainwright & Co.	—	Buy	—
2026-02-25	BTIG	—	Buy	—
2026-02-25	Mizuho	—	Outperform	—
2026-02-24	Chardan Capital	—	Buy	—
2026-01-16	BTIG	—	Buy	—
2025-12-16	Chardan Capital	—	Buy	—
2025-12-16	Canaccord Genuity	—	Buy	—
2025-12-16	TD Cowen	—	Buy	—
2025-12-16	Truist Securities	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-3.88	$26.7K	12
Fri Dec 31	$-4.99	$24.9M	9
Sun Dec 31	$-0.74	$126.3M	9
Mon Dec 31	$7.28	$308.0M	3